CyCa OncoSolutions, founded by Dr Nusrat Jahan M. Sanghamitra placed third at the She Loves Tech Global Startup Competition held a few days ago in Beijing. The Odisha-based entrepreneur was honoured for her path-breaking development of cancer drug delivery device.
'She Loves Tech' is a platform that is building a global ecosystem for technology, entrepreneurship and innovation, opening up opportunities for women. CyCa OncoSolutions first placed at She Loves Tech India that was organized by the KSUM in Kochi. Consequently, the KSUM sent Dr. Nusrat to Beijing for a four day boot camp post which Dr. Nusrat made it to the global summit bagging the third prize.
In 2017, CyCa OncoSolutions started its operations from KIIT-TBI in Bhubaneswar, following which it moved to NCL Innovation Park in Pune. Simultaneously, the company also has a branch operating from the University College, Cork, in Ireland.
The startup, mentored by Kerala Startup Mission (KSUM), developed an 'efficient, non-toxic invitro and in vivo' delivery method to battle cancer. It is a molecular drilling device that can directly inject the anti-cancer drugs to the affected cells with precision.
The summit had 15 women-led enterprises from across the globe for the final round, where they presented their startup products and ideas. The first two prizes were won by startups from Germany and the US respectively.
CyCa OncoSolutions has emerged victorious for making the treatment of cancer safer and better. The device developed by CyCa uses nano technology and has been proved effective in delivering anti-cancer medication. It is expected to cause minimal harm to the unaffected cells, thereby reducing the side-effects. It is believed to have the potential to improve the quality of lives of almost 15 million cancer patients globally.
Dr Nusrat says about the innovation, “This technology can also sharply bring down the economic and social cost of managing cancer, which especially is a major issue with public healthcare systems world over.”
Dr. Nusrat’s startup can also be used to deliver antibiotics into drug resistant microbes and as a one-shot gene therapy tool box.
Dr. Nusrat was initially a researcher and scientist in the field of chemistry and was motivated to find a better anti-cancer drug with lesser side effects. This led to her shifting her research to protein engineering, biophysics, and cell biology, and then venturing into entrepreneurship where she is contributing to the global fight against cancer.